Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

127.1K
Overview
127.1K
Aging01:26

Aging

636
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
636
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Humoral Immune Responses01:36

Humoral Immune Responses

83.5K
Overview
83.5K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

3.4K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.4K
Active versus Passive Immunity01:31

Active versus Passive Immunity

10.1K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroprotective Dihydro-β-agarofuran-Type Sesquiterpenes from the Seeds of <i>Euonymus maackii</i>.

Journal of natural products·2019
Same author

Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene.

Stem cell research·2019
Same author

An induced pluripotent stem cells line (SDQLCHi014-A) derived from urine cells of a patient with ASD and hyperactivity carrying a 303 kb de novo deletion at chr3p26.1 implicating GRM7 gene.

Stem cell research·2019
Same author

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.

Cancer discovery·2019
Same author

Generation of an iPSC line (SDQLCHi015-A) from peripheral blood mononuclear cells of a patient with mental retardation type 15 carrying c.1007_1011del, p.(Ile336fs) in CUL4B gene.

Stem cell research·2019
Same author

Lycodine-type alkaloids from Lycopodiastrum casuarinoides and their acetylcholinesterase inhibitory activity.

Fitoterapia·2019
Same journal

Dehydroleucodine Induces ROS-Mediated Mitochondrial Apoptosis and G2/M Cell Cycle Arrest in Oral Squamous Cell Carcinoma.

Journal of Cancer·2026
Same journal

CellVizio<sup>®</sup> System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons.

Journal of Cancer·2026
Same journal

Epidemiological Trends and Shared Molecular Signatures of Pancreatic Ductal Adenocarcinoma and Diabetes: An Integrative Analysis Based on Global Burden of Disease and Gene Expression Omnibus Datasets.

Journal of Cancer·2026
Same journal

Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.

Journal of Cancer·2026
Same journal

Exosomes in Cancer Biology: Emerging Biomarkers and Therapeutic Targets.

Journal of Cancer·2026
Same journal

<i>GALNT14</i>-rs9679162 Genotypes Predict Post-immunotherapy Side Effect and Survival in Patients with Hepatitis B Virus-related Hepatocellular Carcinoma.

Journal of Cancer·2026
See all related articles

Related Experiment Video

Updated: Jan 22, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

2.0K

Aging, Cancer and Immunity.

Hong Hong1, Qi Wang1, Jing Li1,2,3

  • 1Department of Geriatrics, The First Hospital of China Medical University, Shenyang, 110001, China.

Journal of Cancer
|July 9, 2019
PubMed
Summary
This summary is machine-generated.

Older adults can benefit from immune checkpoint blockers (ICBs) for cancer treatment. Despite concerns about immunosenescence, meta-analyses show ICBs are effective and safe in the elderly population.

Keywords:
AgingCancerImmunityImmunosenescenceImmunotherapy

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Related Experiment Videos

Last Updated: Jan 22, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

2.0K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Area of Science:

  • Oncology
  • Immunology
  • Geriatrics

Background:

  • Cancer incidence and severity increase with age, linked to immunosenescence.
  • Immune checkpoint blockers (ICBs) targeting CTLA-4, PD-1, or PD-L1 show promise in treating various cancers.
  • Limited data exist on ICB efficacy and safety in elderly cancer patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of ICBs in the elderly cancer patient population.
  • To address the impact of immunosenescence and age-related factors on ICB treatment outcomes.

Main Methods:

  • Meta-analysis of clinical studies on ICBs.
  • Assessment of efficacy and toxicity in older adult cohorts.

Main Results:

  • Meta-analyses indicate encouraging efficacy of ICBs in older patients.
  • Older patients appear to benefit from ICBs without increased toxicity.
  • Clinical specificity and immunosenescence may influence outcomes but do not preclude benefit.

Conclusions:

  • ICBs represent a significant advancement in cancer therapy for the elderly.
  • Older cancer patients can likely benefit from the ICB revolution.
  • Further research should focus on optimizing ICB use in this demographic.